Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Vet Group is a biotechnology company focused on the development and commercialization of science-based health and nutrition products for the poultry industry. The company specializes in probiotics and direct-fed microbials that promote gut health and provide alternatives to antibiotic growth promoters. Its flagship products, including FloraMax-B11 and Sporulin, are designed to improve performance and reduce the prevalence of pathogens like Salmonella in commercial flocks. Originally a spin-off from the University of Arkansas, the company was acquired by Novus International in 2014. Today, its technologies are integrated into Novus's global animal health portfolio, continuing to serve the poultry production sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Vet Group.